FY2025 · period end Dec '25 · from the 10-K filed Feb 24, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.54B | $0.51B | $0.55B | $0.59B | $0.51B |
| Gross Profit | $0.21B | $0.19B | $0.19B | $0.21B | $0.18B |
| Operating Income | $0.08B | $0.07B | $0.08B | $0.09B | $0.08B |
| Net Income | $0.07B | $0.06B | $0.06B | $0.06B | negative: -$0.04B |
| EPS (Diluted) | $2.19 | $1.81 | $1.92 | $1.85 | negative: -$1.30 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.76B | $0.77B | $0.74B | $0.75B | $0.66B |
| Total Liabilities | $0.21B | $0.24B | $0.21B | $0.24B | $0.20B |
| Stockholders' Equity | $0.55B | $0.53B | $0.53B | $0.51B | $0.46B |
| Cash & Equivalents | $0.08B | $0.09B | $0.16B | $0.16B | $0.14B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.10B | $0.10B | $0.09B | $0.12B | $0.09B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 38.4% | 36.4% | 34.7% | 35.9% | 36.0% |
| Operating Margin | 0.2% | 0.1% | 0.1% | 0.2% | negative: -0.1% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | negative: -0.1% |
| Return on Equity | 12.1% | 10.5% | 11.7% | 12.3% | negative: -9.4% |
| Return on Assets | 8.5% | 7.4% | 8.1% | 8.4% | negative: -6.5% |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001193125-26-320492 | Jun 30, 2026 | Jul 28, 2026 | Jul 28, 2026 18:10 UTC | EDGAR |
| 8-K | 0001193125-26-318919 | Jul 28, 2026 | Jul 28, 2026 | Jul 28, 2026 12:05 UTC | EDGAR |
| 8-K | 0001193125-26-318911 | Jul 28, 2026 | Jul 28, 2026 | Jul 28, 2026 12:00 UTC | EDGAR |
| 8-K | 0001193125-26-282712 | Jun 25, 2026 | Jun 25, 2026 | Jun 25, 2026 20:00 UTC | EDGAR |
| 8-K | 0001193125-26-230702 | May 14, 2026 | May 19, 2026 | May 19, 2026 20:00 UTC | EDGAR |
| 10-Q | 0001193125-26-190431 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 16:40 UTC | EDGAR |
| 8-K | 0001193125-26-189091 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 12:05 UTC | EDGAR |
| 8-K | 0001193125-26-189074 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 12:00 UTC | EDGAR |
Direct links to SEC EDGAR. CTS has additional filings available on the SEC site.
6 numbers CTS CORP later changed — same XBRL tag, both filings linked.
Net Cash Provided by (Used in) Operating Activities·Q1 2016
Major restatementwas$353K
Revised up in a 10-Q. Any P/OCF built on the original was 87.5% too high.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q2 2013
Major restatementwas$783K
Revised up in a 10-Q.
Operating Income (Loss)·3 months to Jun 2012
Major restatementwas$5.7M
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2011
Major restatementwas$26.3M
Revised down in a 10-K.
Operating Income (Loss)·Q3 2012
Major restatementwas$6.8M
Revised down in a 10-K.
Operating Income (Loss)·FY 2011
Major restatementwas$25.2M
Revised down in a 10-K.
CTS is not the only one.
See every restatement we've found across the market — or get an alert the next time CTS revises a number.
Restatements are detected by comparing every vintage of a fact across all of CTS CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CTS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling CTS CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CTS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CTS and publish the result to your public profile.
Ask about CTS CORP
Continue in Workspace — cited answers on CTS, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs